Home
>
National Drug Code (NDC)
>
Carisoprodol, Aspirin and Codeine Phosphate
Carisoprodol, Aspirin and Codeine Phosphate - 64980-176-01 - (Carisoprodol, Aspirin and Codeine Phosphate)
Drug Information of Carisoprodol, Aspirin and Codeine Phosphate
| Product NDC: | 64980-176 |
| Proprietary Name: | Carisoprodol, Aspirin and Codeine Phosphate |
| Non Proprietary Name: | Carisoprodol, Aspirin and Codeine Phosphate |
| Active Ingredient(s): | 325; 200; 16 mg/1; mg/1; mg/1 & nbsp; Carisoprodol, Aspirin and Codeine Phosphate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Carisoprodol, Aspirin and Codeine Phosphate
| Product NDC: | 64980-176 |
| Labeler Name: | Rising Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040860 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100110 |
Package Information of Carisoprodol, Aspirin and Codeine Phosphate
| Package NDC: | 64980-176-01 |
| Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (64980-176-01) |
NDC Information of Carisoprodol, Aspirin and Codeine Phosphate
| NDC Code | 64980-176-01 |
| Proprietary Name | Carisoprodol, Aspirin and Codeine Phosphate |
| Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (64980-176-01) |
| Product NDC | 64980-176 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Carisoprodol, Aspirin and Codeine Phosphate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100110 |
| Marketing Category Name | ANDA |
| Labeler Name | Rising Pharmaceuticals, Inc. |
| Substance Name | ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE |
| Strength Number | 325; 200; 16 |
| Strength Unit | mg/1; mg/1; mg/1 |
| Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
